Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1973 1
1974 2
1976 1
1978 1
1984 1
1991 2
1992 2
1993 2
1995 1
1996 7
1997 1
1998 2
1999 2
2000 1
2001 3
2002 1
2003 2
2004 2
2005 9
2006 4
2007 4
2008 6
2009 17
2010 14
2011 20
2012 23
2013 16
2014 6
2015 12
2016 13
2017 9
2018 10
2019 5
2020 5
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

192 results
Results by year
Filters applied: . Clear all
Page 1
Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study.
Raje N, Terpos E, Willenbacher W, Shimizu K, García-Sanz R, Durie B, Legieć W, Krejčí M, Laribi K, Zhu L, Cheng P, Warner D, Roodman GD. Raje N, et al. Among authors: krejci m. Lancet Oncol. 2018 Mar;19(3):370-381. doi: 10.1016/S1470-2045(18)30072-X. Epub 2018 Feb 9. Lancet Oncol. 2018. PMID: 29429912 Clinical Trial.
Aging, hormones and receptors.
Hill M, Třískala Z, Honců P, Krejčí M, Kajzar J, Bičíková M, Ondřejíková L, Jandová D, Sterzl I. Hill M, et al. Among authors: krejci m. Physiol Res. 2020 Sep 30;69(Suppl 2):S255-S272. doi: 10.33549/physiolres.934523. Physiol Res. 2020. PMID: 33094624 Free article.
Plasma Cell Leukemia –  the Forgotten Dis­ease.
Žárska M, Vrábel D, Bezdekova R, Štork M, Jarošová M, Adam Z, Krejčí M, Pour L, Ševčíková S. Žárska M, et al. Among authors: krejci m. Klin Onkol. 2019 Winter;32(1):40-46. Klin Onkol. 2019. PMID: 30764628 Review. English.
Multiple myeloma.
Hájek R, Krejcí M, Pour L, Adam Z. Hájek R, et al. Among authors: krejci m. Klin Onkol. 2011;24 Suppl:S10-3. Klin Onkol. 2011. PMID: 21923057 Review.
Biobanking - the First Step to Successful Liquid Biopsy Experiments.
Almasi M, Sevcikova S, Penka M, Krejci M, Adam Z, Vrublova P, Jelínek T, Hájek R. Almasi M, et al. Among authors: krejci m. Klin Onkol. 2017 Summer;30(Supplementum2):9-12. doi: 10.14735/amko20172S9. Klin Onkol. 2017. PMID: 28903566 Review. English.
Melphalan 140 mg/m2 or 200 mg/m2 for autologous transplantation in myeloma: results from the Collaboration to Collect Autologous Transplant Outcomes in Lymphoma and Myeloma (CALM) study. A report by the EBMT Chronic Malignancies Working Party.
Auner HW, Iacobelli S, Sbianchi G, Knol-Bout C, Blaise D, Russell NH, Apperley JF, Pohlreich D, Browne PV, Kobbe G, Isaksson C, Lenhoff S, Scheid C, Touzeau C, Jantunen E, Anagnostopoulos A, Yakoub-Agha I, Tanase A, Schaap N, Wiktor-Jedrzejczak W, Krejci M, Schönland SO, Morris C, Garderet L, Kröger N. Auner HW, et al. Among authors: krejci m. Haematologica. 2018 Mar;103(3):514-521. doi: 10.3324/haematol.2017.181339. Epub 2017 Dec 7. Haematologica. 2018. PMID: 29217776 Free PMC article. Clinical Trial.
Donor-derived DNA variability in fingernails of acute myeloid leukemia patients after allogeneic hematopoietic stem cell transplantation detected by direct PCR.
Robesova B, Drncova M, Folta A, Krejci M, Folber F, Sustkova Z, Mayer J, Jeziskova I. Robesova B, et al. Among authors: krejci m. Bone Marrow Transplant. 2020 Jun;55(6):1021-1022. doi: 10.1038/s41409-020-0938-x. Epub 2020 May 9. Bone Marrow Transplant. 2020. PMID: 32388533 No abstract available.
Bortezomib and Thalidomide Treatment Results in Newly Diagnosed Transplant-Ineligible Multiple Myeloma Patients are Comparable in Long-Term Follow-Up.
Stork M, Sandecká V, Boichuk I, Adam Z, Krejci M, Brozova L, Sevcikova S, Pour L. Stork M, et al. Among authors: krejci m. Klin Onkol. 2019 Fall;32(6):445-452. doi: 10.14735/amko2019445. Klin Onkol. 2019. PMID: 31842563 English.
Histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Comparison of recent WHO classification published 2017 and classification of Histiocyte Society published 2016.
Král Z, Adam Z, Ježová M, Pour L, Krejčí M. Král Z, et al. Among authors: krejci m. Vnitr Lek. 2020 Summer;66(6):19-27. Vnitr Lek. 2020. PMID: 33380149 English.
Minimal Residual Disease Assessment in Multiple Myeloma by Multiparametric Flow Cytometry.
Rihova L, Vsianska P, Bezdekova R, Kralova R, Penka M, Krejci M, Pour L, Hájek R. Rihova L, et al. Among authors: krejci m. Klin Onkol. 2017 Summer;30(Supplementum2):21-28. doi: 10.14735/amko20172S21. Klin Onkol. 2017. PMID: 28903567 Review. English.
192 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback